|
Feb 17
|
BioCryst Pharmaceuticals (BCRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
|
Feb 12
|
BioCryst Launches ORLADEYO® (berotralstat) in Portugal
|
|
Feb 10
|
Exploring Three High Growth Tech Stocks In The United States
|
|
Feb 10
|
BioCryst to Present New ORLADEYO® (berotralstat) Results from APeX-P Pediatric Trial at 2025 American Academy of Allergy, Asthma & Immunology / World Allergy Organization Joint Congress
|
|
Feb 10
|
BioCryst to Report Fourth Quarter 2024 Financial Results on February 24
|
|
Jan 14
|
BioCryst price target raised to $12 from $10 at Evercore ISI
|
|
Jan 10
|
Exploring High Growth Tech Stocks In January 2025
|
|
Jan 10
|
BioCryst Announces Preliminary Full Year 2024 ORLADEYO® (berotralstat) Net Revenue of $437 Million (+34 percent y-o-y)
|
|
Jan 7
|
BioCryst to Present at 43rd Annual J.P. Morgan Healthcare Conference
|
|
Oct 11
|
Is BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) The Top Stock With Improving Technical Ratings According To Piper Sandler?
|
|
Oct 10
|
BioCryst to Present New Real-World Evidence on Long-Term Prophylaxis in HAE, including ORLADEYO® (berotralstat), at the American College of Allergy, Asthma & Immunology 2024 Annual Scientific Meeting
|
|
Oct 9
|
BioCryst Pharmaceuticals, Inc. (BCRX) Surpasses Revenue Expectations by $11 Million in Q2
|
|
Oct 7
|
BioCryst (BCRX) Upgraded to Buy: Here's Why
|
|
Oct 2
|
Enanta Pharmaceuticals (ENTA) Surges 5.6%: Is This an Indication of Further Gains?
|
|
Oct 2
|
BioCryst Begins Enrollment in Phase 1 Trial Evaluating BCX17725, a KLK5 Inhibitor, for the Treatment of Netherton Syndrome
|
|
Oct 1
|
BioCryst Secures Major US Health Department Influenza Drug Deal
|
|
Oct 1
|
BioCryst secures $69m contract from US to supply RAPIVAB for influenza
|
|
Sep 30
|
With 80% institutional ownership, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is a favorite amongst the big guns
|
|
Sep 30
|
U.S. Government Awards BioCryst $69 Million RAPIVAB® (peramivir injection) Contract for Strategic National Stockpile
|
|
Sep 6
|
BioCryst Presents New ORLADEYO® (berotralstat) Data at 7th Bradykinin Symposium
|